These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31894538)

  • 21. Protective Effect of Fasudil on Hydrogen Peroxide-Induced Oxidative Stress Injury of H9C2 Cardiomyocytes.
    Zhang Y; Liu S; Li X; Ye J
    Dis Markers; 2021; 2021():8177705. PubMed ID: 34900030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyl fasudil, an inhibitor of Rho signaling, improves erectile function in diabetic rats: a role for neuronal ROCK.
    Sezen SF; Lagoda G; Musicki B; Burnett AL
    J Sex Med; 2014 Sep; 11(9):2164-71. PubMed ID: 24919622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
    Na W; Peng G; Jianping Z; Yanzhong C; Shengjiang G; Li C
    Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
    Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
    J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
    Guan SJ; Ma ZH; Wu YL; Zhang JP; Liang F; Weiss JW; Guo QY; Wang JY; Ji ES; Chu L
    Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity.
    Deepa PR; Varalakshmi P
    Chem Biol Interact; 2003 Oct; 146(2):201-10. PubMed ID: 14597133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
    Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
    J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
    Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compound Danshen Dripping Pill inhibits doxorubicin or isoproterenol-induced cardiotoxicity.
    Feng K; Liu Y; Sun J; Zhao C; Duan Y; Wang W; Yan K; Yan X; Sun H; Hu Y; Han J
    Biomed Pharmacother; 2021 Jun; 138():111531. PubMed ID: 34311530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
    Deng L; Li G; Li R; Liu Q; He Q; Zhang J
    Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
    J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of Piper longum L. on oxidative stress induced injury and cellular abnormality in adriamycin induced cardiotoxicity in rats.
    Wakade AS; Shah AS; Kulkarni MP; Juvekar AR
    Indian J Exp Biol; 2008 Jul; 46(7):528-33. PubMed ID: 18807757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasudil ameliorates cognitive deficits, oxidative stress and neuronal apoptosis via inhibiting ROCK/MAPK and activating Nrf2 signalling pathways in APP/PS1 mice.
    Wei W; Wang Y; Zhang J; Gu Q; Liu X; Song L; Chai Z; Guo M; Yu J; Ma C
    Folia Neuropathol; 2021; 59(1):32-49. PubMed ID: 33969676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fasudil on cognitive function following status convulsion in rats.
    He R; Han W; Song X; Tang X; Cheng L; Jiang L
    Mol Med Rep; 2017 Jul; 16(1):119-126. PubMed ID: 28534935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quercetin Reverses Altered Energy Metabolism in the Heart of Rats Receiving Adriamycin Chemotherapy.
    Zakaria N; Khalil SR; Awad A; Khairy GM
    Cardiovasc Toxicol; 2018 Apr; 18(2):109-119. PubMed ID: 28702745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
    Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
    J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.